Legato Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,380
| Closed | -$237K | – | 585 |
|
|
2024
Q2 | $237K | Buy |
+4,380
| New | +$237K | 0.03% | 511 |
|
|
2024
Q1 | – | Sell |
-15,636
| Closed | -$1.31M | – | 577 |
|
|
2023
Q4 | $1.31M | Buy |
+15,636
| New | +$1.31M | 0.17% | 192 |
|
|
2023
Q2 | – | Sell |
-14,038
| Closed | -$494K | – | 588 |
|
|
2023
Q1 | $494K | Sell |
14,038
-2,897
| -17% | -$102K | 0.09% | 360 |
|
|
2022
Q4 | $776K | Buy |
+16,935
| New | +$776K | 0.15% | 240 |
|